{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:15:13Z","timestamp":1789748113193,"version":"4.0.1"},"reference-count":101,"publisher":"Informa UK Limited","issue":"11","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Immunology"],"published-print":{"date-parts":[[2023,11,2]]},"DOI":"10.1080\/1744666x.2023.2247158","type":"journal-article","created":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T10:26:37Z","timestamp":1691663197000},"page":"1325-1342","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":12,"title":["Malignancies and rheumatoid arthritis, csDMARDs, biological DMARDs, and JAK inhibitors: challenge and outlook"],"prefix":"10.1080","volume":"19","author":[{"given":"Koshiro","family":"Sonomoto","sequence":"first","affiliation":[{"name":"Department of Clinical Nursing, School of Health Sciences, University of Occupational and Environmental Health Japan, Fukuoka, Japan"},{"name":"The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health Japan, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiya","family":"Tanaka","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health Japan, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,8,14]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-021-00726-8"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2019.03.011"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10030509"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2109927"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature07205"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-015-0728-9"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1050876"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140533"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003540"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/mr\/roac085"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4609486"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12060965"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar2904"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2017.4332"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208105"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21675"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.40017"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2021.1899570"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22579"},{"issue":"2","key":"e_1_3_4_22_1","first-page":"322","article-title":"Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication","volume":"34","author":"Hoshida Y","year":"2007","unstructured":"Hoshida Y, Xu JX, Fujita S, et al. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol. 2007 Feb;34(2):322\u2013331.","journal-title":"J Rheumatol"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12116"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1022769"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13249"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2017.1369073"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001271"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2021.1879362"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01620-2"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2013.08.003"},{"key":"e_1_3_4_31_1","first-page":"110","article-title":"Risk of malignant melanoma and non-melanoma skin cancer in rheumatoid arthritis patients initiating methotrexate versus hydroxychloroquine: a cohort study","volume":"41","author":"Lee H","year":"2023","unstructured":"Lee H, Chen SK, Gautam N, et al. Risk of malignant melanoma and non-melanoma skin cancer in rheumatoid arthritis patients initiating methotrexate versus hydroxychloroquine: a cohort study. Clin Exp Rheumatol. 2023 Jan;41:110\u2013117.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1809798"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.7326\/M19-3369"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11187"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.11.044"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.11.043"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.19.2275"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.091025"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.2046"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.30310"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1001\/2012.jama.10857"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0048991"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-011-1895-y"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.7314\/APJCP.2014.15.8.3403"},{"key":"e_1_3_4_45_1","first-page":"CD012591","article-title":"Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis","volume":"3","author":"Singh JA","unstructured":"Singh JA, Hossain A, Tanjong Ghogomu E, et al. Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2017 Mar 10;3: CD012591","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.149419"},{"issue":"5","key":"e_1_3_4_47_1","first-page":"756","article-title":"Risk of malignancy including non-melanoma skin cancers with anti-tumor necrosis factor therapy in patients with rheumatoid arthritis: meta-analysis of registries and systematic review of long-term extension studies","volume":"30","author":"Le Blay P","year":"2012","unstructured":"Le Blay P, Mouterde G, Barnetche T, et al. Risk of malignancy including non-melanoma skin cancers with anti-tumor necrosis factor therapy in patients with rheumatoid arthritis: meta-analysis of registries and systematic review of long-term extension studies. Clin Exp Rheumatol. 2012 Sep;30(5):756\u2013764.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2017.81"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2010.08.005"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201969"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f1939"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.37740"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-014-0449-5"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204851"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208263"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1186\/s41927-018-0050-7"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-022-02868-w"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key352"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-1921-z"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-1992-x"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez604"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2015-000213"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2019.03.002"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2010.11.012"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150051"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2016.1141740"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa330"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-002139"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200622"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205745"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39738"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew314"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212086"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.7326\/M17-2812"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez475"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2023-eular.4884"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2023-eular.4789"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac710"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020-001395"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221276"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221051"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002735"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-223916"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11232"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1093\/mr\/roac089"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reuma.2021.08.001"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead079"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead163"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13317-021-00153-5"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224049"},{"key":"e_1_3_4_91_1","unstructured":"U.S. Food and Drug Administration. FDA requires warnings about increased risk of serious heart-related events cancer blood clots and death for JAK inhibitors that treat certain chronic inflammatory conditions. 2021; [cited May 21 2023]. Available from: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-requires-warnings-about-increased-risk-serious-heart-related-events-cancer-blood-clots-and-death"},{"key":"e_1_3_4_92_1","unstructured":"European Medicines Agency. Cibinqo (abrocitinib) Jyseleca (filgotinib) Olumiant (baricitinib) Rinvoq (upadacitinib) and Xeljanz (tofacitinib) \u2013 updated recommendations to minimise the risks of malignancy major adverse cardiovascular events serious infections venous thromboembolism and mortality with use of Janus kinase inhibitors (JAKi). 2023; [cited May 21 2023]. Available from: https:\/\/www.ema.europa.eu\/documents\/dhpc\/direct-healthcare-professional-communication-dhpc-updated-recommendations-minimise-risks-malignancy_en.pdf"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223715"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-222543"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-022-00976-5"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204021"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209233"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-017-0064-4"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key208"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead075"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2009.427"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.30134"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020-001512"}],"container-title":["Expert Review of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/1744666X.2023.2247158","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T16:55:43Z","timestamp":1698166543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/1744666X.2023.2247158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,14]]},"references-count":101,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11,2]]}},"alternative-id":["10.1080\/1744666X.2023.2247158"],"URL":"https:\/\/doi.org\/10.1080\/1744666x.2023.2247158","relation":{},"ISSN":["1744-666X","1744-8409"],"issn-type":[{"value":"1744-666X","type":"print"},{"value":"1744-8409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,14]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-05-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}